Detalhe da pesquisa
1.
Cannabinoid 1 and mu-Opioid Receptor Agonists Synergistically Inhibit Abdominal Pain and Lack Side Effects in Mice.
J Neurosci
; 42(33): 6313-6324, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790401
2.
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
Gut
; 71(4): 695-704, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785555
3.
Changes in signalling from faecal neuroactive metabolites following dietary modulation of IBS pain.
Gut
; 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591617
4.
Protease-Induced Excitation of Dorsal Root Ganglion Neurons in Response to Acute Perturbation of the Gut Microbiota Is Associated With Visceral and Somatic Hypersensitivity.
Cell Mol Gastroenterol Hepatol
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38494056
5.
Evolving acidic microenvironments during colitis provide selective analgesic targets for a pH-sensitive opioid.
Pain
; 164(11): 2501-2515, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326658
6.
Dietary monosodium glutamate increases visceral hypersensitivity in a mouse model of visceral pain.
Neurogastroenterol Motil
; 35(9): e14596, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248774